Filana Therapeutics, Inc. (FLNA)

Price & Market Data

Price: $1.21

Daily Change: -$0.07 / 5.79%

Daily Range: $1.20 - $1.30

Market Cap: $57,969,476

Daily Volume: 480,087

Performance Metrics

1 Week: -13.04%

1 Month: -25.93%

3 Months: -44.95%

6 Months: -59.46%

1 Year: -34.43%

YTD: -39.39%

About Filana Therapeutics, Inc. (FLNA)

Discover key statistics for Filana Therapeutics, Inc. (FLNA). The stock is trading at 1.21, reflecting a daily change of -$0.07 / 5.79%. Its market capitalization is 57,969,476. Review its performance history, including 1-week and 1-year trends.

Company Details

Employees: 20

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.

Selected stocks

Information Services Group, Inc. (III)

WhiteHorse Finance, Inc. (WHF)

F.N.B. Corporation (FNB)

Atossa Therapeutics, Inc. (ATOS)

BioXcel Therapeutics, Inc. (BTAI)